Back to EZorb Newsletter Index





In this issue:


1. Share Success: Letters From Readers
2. Research News: Guidelines for Small Renal Masses Questioned
3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb and Marvlix?

1. Share Success: Letters From Readers 


Letter I: From JV

Received at ezorb @ Thursday, April 2, 2015 5:41 PM



Thank you so much for taking the time to answer my inquiry. Now that I understand the 'cause' of this "disease", I have every reason to believe that Ezorb taken as prescribed will strengthen my friends bones and do just as you've said.

My confidence is sure because Ezorb has done wonders for my 'skeleton'. I have suffered 2 very freaky, accidental falls in the past 4 years, both of which should have broken me up very badly. In both cases before arising from the concrete pavement, I prayed and asked for help to get up. Not only was I able to get up on my own but never suffered bone fractures of any sort.

In one case I had Xrays, around my neck and jaws, and the technician declared all was well. That fall was filmed on surveillance cameras. Everyone who watched marveled that I had not broken my neck.

So, my first confidence is in God, of course, for it was He who lead me to your Ezorb site. My doctor had told me, over 10 years ago that I had osteopenia and strongly advised me to take Formosa to build up my bones.

I went home and Googled osteopenia and your popped up.

I said, "YES! NO Drugs!" and ordered EZorb immediately. We stopped the big 'O' in its tracks and instead began to build up a very strong skeleton. I am a 74 years 'young' woman and enjoying life to the MAX! I take Marvlix as well, and am very happy with both products. And, yes, I tell anyone who will listen about the results I've had.

I am very thankful for the work you are doing and for providing these excellent and very effective products.

May you be blessed for your humanitarian efforts. I pray JehoVah's favor and Wisdom upon you as you continue with your research and kindness to the likes of me.


Letter II: From Harriet L.

Received at Testimonial Submit Form Monday, December 22, 2014 7:06 AM



My husband has CKD and CHF. He started taking the cordyceps about three months ago, and his last blood work showed improvement...happy to report.

Letter III: From Ivy


Received at Testimonial Submit Form Monday, October 06, 2014 at 05:00:00



Hi, my name is Ivy. I have been treating my heel spurs with esorb capsules and they give me relief almost immediately. Now I have developed osteoporosis and my Dr has prescribed Fosavance!! Can I continue taking my esorb as well?


From the Desk of EZorb Newsletter Editor:

This newsletter is now read by over 70,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's quality of life. Your continuous support will be greatly appreciated by tens of thousands who have been suffering and would continuously suffer, without your help! Please email your story to sharesuccess @ or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public.

2. Research News: Guidelines for Small Renal Masses Questioned


Partial nephrectomy (PN) and percutaneous ablation for small and localized renal masses produce similar rates of local tumor recurrence, report US researchers.

They say these data suggest there should be an update to the American Urological Association's guidelines for renal masses, which recommends that PN should be strongly considered for healthy patients with cT1a renal masses and should be discussed as an alternate standard for cT1b patients.

Led by Robert Houston Thompson (Mayo Clinic, Rochester, Minnesota, USA) the group compared local recurrence-free, metastases-free, and overall survival among patients treated with PN, percutaneous radiofrequency ablation (RFA), and percutaneous cryoablation for sporadic and localized solid renal masses.

Of the 1803 patients included in the study, 1424 had cT1a tumors and 379 had cT1b tumors. For patients with cT1a renal masses, 1057 underwent PN, 180 underwent RFA, and 187 underwent cryoablation.

The researchers observed that recurrence-free survival was similar among the three treatment groups at 3 years, whereas metastases-free survival was inferior for RFA compared with the other treatments, and overall survival was superior for PN.

Of the cT1b patients, 326 underwent PN and 53 patients were managed with cryoablation. Eight patients underwent RFA but were excluded from the final analysis.

The researchers found that recurrence-free survival and metastases-free survival were similar for PN and cryoablation patients, while overall survival again favored PN patients. However Thompson et al note that this is likely reflective of selection bias.

"To our knowledge, these results represent the first comparison of oncologic outcomes among PN, percutaneous RFA, and percutaneous cryoablation patients at a single center with extensive experience in each technique", they write in European Urology.

"In a large cohort of sporadic cT1 renal masses, we observed that recurrence-free survival was similar for PN and percutaneous ablation patients."

The team concludes: "If validated, these data suggest that an update to clinical guidelines would be warranted."

Original research was published in Eur Urol 2014; Advance online publication.

3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now



4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ for a copy of the instructions.



5. What Are Others Saying About EZorb and Marvlix?

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.

Back to EZorb Newsletter Index

  Copyright 2015 Elixir Industry